Skip to main content
JAMA Network logoLink to JAMA Network
. 2022 Mar 22;5(3):e225937. doi: 10.1001/jamanetworkopen.2022.5937

Errors in Figures

PMCID: PMC8941345  PMID: 35315924

In the Original Investigation titled “Mortality Rates Among Hospitalized Patients With COVID-19 Infection Treated With Tocilizumab and Corticosteroids: A Bayesian Reanalysis of a Previous Meta-analysis,”1 published February 28, 2022, errors occurred in 2 figures. In Figures 1B and 2B, the x-axis label was incorrectly published as “OR (95% CI)”; that label should have appeared as “OR.” This article has been corrected.1

Reference

  • 1.Albuquerque AM, Tramujas L, Sewanan LR, Williams DR, Brophy JM. Mortality rates among hospitalized patients with COVID-19 infection treated with tocilizumab and corticosteroids: a bayesian reanalysis of a previous meta-analysis. JAMA Netw Open. 2022;5(2):e220548. doi: 10.1001/jamanetworkopen.2022.0548 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAMA Network Open are provided here courtesy of American Medical Association

RESOURCES